Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune tolerance induction refers to the physiological processes by which the immune system becomes unresponsive (tolerant) to specific antigens, preventing harmful immune reactions against self-tissues (autoimmunity), transplanted organs, allergens, or other non-threatening substances. This state of unresponsiveness can be naturally established during development (central tolerance) or actively maintained in peripheral tissues throughout life (peripheral tolerance).
Interrupting effector pathways, Restraining innate activation, Enhancing regulatory networks
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune tolerance induction.